The Progression of Prion Diseases Is Not Altered in the Absence of TMEM106B
It is demonstrated that the absence of TMEM106B does not alter the progression of prion diseases in any of the tested conditions, which provides supportive evidence on the specificity of TMEM106B in neurodegenerative conditions.